PATENT CLAIM ANALYSIS

Application Number: 15782014
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "085100"]

Abstract:
The present invention relates to methods of improving blastocyst implantation by delivering adrenomedullin to the endometrium of a subject. The invention further relates to methods of performing in vitro fertilization.

Claim (Index 8):
The method of  claim 2 , wherein the adrenomedullin is delivered to the endometrium no more than 24 hours prior to delivery of the blastocyst.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 94.0
- Lexical Diversity: 1.3913
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15538639', '14643307', '13626271', '11370152', '13392133']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6810125219959617
- 35 USC 102 Novelty (BERT): 0.4961371791477486
- Combined Prediction Score: 0.6625249877111404
- Mean Citation Score: 170.478328
- Max Citation Score: 177.61713999999995
- Similarity Product: 119.17719508594392

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test